Novel strategies are needed to expand equitable access to penicillin allergy testing. We performed a pilot study of penicillin allergy testing through direct challenges performed at pediatric primary care group office visits. Ninety-five percent of subjects were delabeled with no severe reactions noted, providing conceptual basis for further implementation studies.
Keywords: delabeling; drug challenge; infectious disease; penicillin allergy; primary care.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.